New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
08:49 EDTABMDAbiomed shares overvalued, says Northland Securities
Northland believes Abiomed utilization rates for Impella are going down on both the ImpellaCP and Impella 2.5. The firm said Abiomed's story is now dependent on new site add-ons where utilization rates haven moved and sees risk to shares. The firm rates Abiomed an Underperform with a $14 price target.
News For ABMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2015
07:16 EDTABMDLeerink to hold a booth tour at EuroPCR
Subscribe for More Information
May 13, 2015
10:07 EDTABMDHigh option volume stocks
Subscribe for More Information
07:31 EDTABMDHeart Rhythm Society to hold a conference
Heart Rhythm 2015 is being held in Boston on May 13-16.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use